PA
ZLAB icon

Parallel Advisors’s Zai Lab ZLAB Stock Holding History

Parallel Advisors’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-27
Closed -$508 – 4088
2026
Q1 		$508 Buy
+27
New +$500 ﹤0.01% 3670
2022
Q1 		– Sell
-673
Closed -$42K – 3313
2021
Q4 		$42K Buy
673
+333
+98% +$28.2K ﹤0.01% 1414
2021
Q3 		$36K Buy
340
+18
+6% +$2.58K ﹤0.01% 1443
2021
Q2 		$57K Buy
322
+16
+5% +$2.57K ﹤0.01% 1190
2021
Q1 		$41K Buy
306
+103
+51% +$15.9K ﹤0.01% 1276
2020
Q4 		$27K Buy
203
+21
+12% +$2.14K ﹤0.01% 1369
2020
Q3 		$15K Buy
182
+70
+63% +$5.62K ﹤0.01% 1573
2020
Q2 		$9K Sell
112
-943
-89% -$63.8K ﹤0.01% 1775
2020
Q1 		$54K Buy
1,055
+22
+2% +$1.15K ﹤0.01% 911
2019
Q4 		$43K Hold
1,033
– – ﹤0.01% 1087
2019
Q3 		$33K Hold
1,033
– – ﹤0.01% 1151
2019
Q2 		$36K Buy
+1,033
New +$30.4K ﹤0.01% 1034

Other funds holding ZLAB

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Parallel Advisors's ZLAB Position: Q2 2026 in Review

Parallel Advisors sold out of Zai Lab (ZLAB) in Q2 2026, closing a stake of 27 shares — an estimated $508 sold.

Parallel Advisors first reported a position in ZLAB in Q2 2019 and held it in 12 quarters. The position peaked at $57K in Q2 2021. 92 funds tracked by Wall St. Rank hold ZLAB as of Q2 2026.

  • Parallel Advisors reported no remaining Zai Lab position as of Q2 2026 after selling out during the quarter.
  • Parallel Advisors sold 27 Zai Lab shares in Q2 2026, an estimated $508.
  • Parallel Advisors first reported a position in Zai Lab in Q2 2019 and held it in 12 quarters.
  • Parallel Advisors's Zai Lab position peaked at $57K in Q2 2021.
  • 92 funds tracked by Wall St. Rank held Zai Lab as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.